Search Grant Opportunities

DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award

ID: HT942524ALSRPCOBA • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

The FY24 ALSRP Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients.

Research may include, but is not limited to:

  • Target engagement biomarkers.
  • Objective pharmacodynamic biomarkers to measure the biological effect of an investigational therapeutic.
  • Predictive/cohort-selective biomarkers that indicate whether a specific therapy will be effective in an individual patient or patient subgroup.
  • Diagnostic, prognostic, or disease progression
  • Validate clinician-, observer-, patient-reported and/or performance outcomes to better support clinical trial success metrics.
  • Define ALS subtypes using patient-based resources to link biosamples and/or digital data elements to rigorous molecular and clinical data.
  • Realize improved strategies that better measure disease progression for people living with ALS.
  • Augment biospecimens, outcome, or digital health data to an on-going clinical trial.
  • Correlate clinical-trial related data (e.g., biosample, imaging, digital health data) with clinical outcomes or responses to therapies.

Use of existing well-characterized and highly curated clinical resources is encouraged. Examples of patient-based ALS resources include ongoing or completed clinical trial datasets, biorepositories of clinical specimens, registries (e.g., Centers for Disease Control and Prevention National ALS Registry and/or Biorepository; https://www.cdc.gov/als/Default.html), large omics datasets, patient-report outcomes, digital biomarker datasets, and databases of clinical data and/or metadata. Active-duty military and/or Veteran patient populations or resources should be considered. A list of suitable resources can be found on the ALSRP web page (https://cdmrp.health.mil/alsrp/resources/ALSRPresources). Other resources may be used, provided they have an adequate description of repository parameters and mechanisms for broad access.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 3/25/24 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942524ALSRPCOBA for DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award with funding of $6.1 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 5 total grants will be made.

Timing

Posted Date
March 25, 2024, 12:00 a.m. EDT
Closing Date
July 10, 2024, 12:00 a.m. EDT Past Due
Last Updated
April 23, 2024, 1:19 p.m. EDT
Version
3
Archive Date
Aug. 9, 2024

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$6,100,000
Estimated Number of Grants
5

Contacts

Contact
Danielle Reckley Grantor
Contact Email
Email Description
CDMRP Help Desk
Contact Phone
(301) 619-1139

Documents

Posted documents for HT942524ALSRPCOBA

Opportunity Assistant


AI Analysis

AI Generate

Grant Awards

Grants awarded through HT942524ALSRPCOBA

Incumbent or Similar Grants

Grants similar to HT942524ALSRPCOBA

Similar Active Opportunities

Open grant opportunities similar to HT942524ALSRPCOBA

Experts for DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award

Recommended subject matter experts available for hire